A3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: Efficacy on clinical signs and impact on the burden of illness

Dominique Bremond-Gignac, Riadh Messaoud, Sihem Lazreg, Claude Speeg-Schatz, Didier Renault, Frédéric Chiambaretta, A. Harrtani, T. Kaercher, M. Khairallah, B. Kocyla, B. Lorenz, B. Mortemousque, J. Murta, H. Nezzar, P. Nucci, J. Salgado-Borges, C. Tataru, M. Tatineanu, L. Voinea

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: Efficacy on clinical signs and impact on the burden of illness'. Together they form a unique fingerprint.

Medicine & Life Sciences